Skip to main content

Type 2 Diabetes News

Type 2 Diabetes is a chronic condition involving high blood sugar levels and reduced production and responsiveness to insulin.     

Janis Roszler on the need for diabetes education.
Recently, MannKind Corporation submitted a “new drug application” for its inhaled insulin candidate, Afrezza, to the FDA. Afrezza, is an ultra rapid-acting mealtime...
AADE Diabetes Educator of the Year Mary Sullivan on teaching diabetes self-care when we need it most – in the inpatient setting.
Kerri Morrone Sparling looks at new paths for 2010.
Following the US approval of Bydureon late last month, the drug became available at pharmacies across the nation in mid-February. Bydureon is the first once-weekly drug...
Kelly talks about and the changes 2009 is bringing in the way people look at diabetes and welcomes a new diabetes management column by Gary Scheiner.
On July 28, the Medingo Solo MicroPump Insulin Delivery System was cleared by the FDA. The Solo is a full-featured “detachable” tubing-free pump, similar to traditional...
An in-depth look at the trials and tribulations a drug must endure on its journey from bench to bedside.
Our frequent contributor, Dana Lewis, alerted us to this handy tool for recording blood glucose numbers during the day. SugarDash is a mini-logbook that you can download...
Traveling to Malawi with type 1 diabetes: four days back home, Jim Hirsch details an amazing (and dramatic) trip to Africa…
Pharmaceutical companies are trying to develop diabetes products that do not promote weight gain. As is, several diabetes drugs have been implicated in inducing weight...
If you’ve ever left your diabetes doctor/educator’s office thinking, “That’s an hour of my life I’d like to have back,” this article is for you.
From Intel Corp. comes a new device to add to your diabetes care toolbox - and it might even help to organize all of your tools. The Intel Health Guide, coming out at...
A ping or two...
We’d like to tell you about a new diabetes management program from J&J’s SymCare branch that has just received FDA approval this month. The program, called inTouch,...
Resolutions gone awry
Diabetes advocate Amy Tenderich is hosting her third annual DiabetesMine Design Challenge, giving you a chance to win funding to help you further your creativity toward...
Is diabetes a disability? James Hirsch’s son, Garrett, wants to know.
On March 6, Animas announced that it had identified a problem with the software on its OneTouch Ping insulin pumps. If patients attempted to change the time and/or date...
(S)he said what??!

Pages